Search research articles
Contact Us
Filters
Showing results (81-90 of 176) with videos related to
Page
of 18
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
November 17, 2009
Ectopic T-bet expression licenses dendritic cells for IL-12-independent priming of type 1 T cells in vitro
Michael W Lipscomb, Lu Chen, Jennifer L Taylor, et al.
Journal for Immunotherapy of Cancer
|
April 21, 2016
Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer
Michal Radomski, Herbert J Zeh, Howard D Edington, et al.
Nature Communications
|
September 2, 2022
Distinct metabolic states guide maturation of inflammatory and tolerogenic dendritic cells
Juraj Adamik, Paul V Munson, Felix J Hartmann, et al.
Journal of Translational Medicine
|
May 23, 2022
The future of cancer immunotherapy for brain tumors: a collaborative workshop
Christine E Brown, Samantha Bucktrout, Lisa H Butterfield, et al.
Cancer Immunology Research
|
May 5, 2017
Tumor-Derived α-Fetoprotein Directly Drives Human Natural Killer-Cell Activation and Subsequent Cell Death
Lazar Vujanovic, Elizabeth C Stahl, Angela D Pardee, et al.
Journal of Translational Medicine
|
April 8, 2021
The "Great Debate" at Immunotherapy Bridge 2020, December 3rd, 2020
Paolo A Ascierto, Joshua Brody, Lisa H Butterfield, et al.
Cancer Gene Therapy
|
March 19, 2005
Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells
Jennifer A Wargo, Lana Y Schumacher, Begonya Comin-Anduix, et al.
JAMA
|
November 5, 2014
Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial
F Stephen Hodi, Sandra Lee, David F McDermott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2013
A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)
Craig L Slingluff, Sandra Lee, Fengmin Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2014
Phase I dendritic cell p53 peptide vaccine for head and neck cancer
Patrick J Schuler, Malgorzata Harasymczuk, Carmen Visus, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 176) with videos related to
Sort By:
Page
of 18
Journal of Immunology (Baltimore, Md. : 1950)
|
November 17, 2009
Ectopic T-bet expression licenses dendritic cells for IL-12-independent priming of type 1 T cells in vitro
Michael W Lipscomb, Lu Chen, Jennifer L Taylor, et al.
Journal for Immunotherapy of Cancer
|
April 21, 2016
Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer
Michal Radomski, Herbert J Zeh, Howard D Edington, et al.
Nature Communications
|
September 2, 2022
Distinct metabolic states guide maturation of inflammatory and tolerogenic dendritic cells
Juraj Adamik, Paul V Munson, Felix J Hartmann, et al.
Journal of Translational Medicine
|
May 23, 2022
The future of cancer immunotherapy for brain tumors: a collaborative workshop
Christine E Brown, Samantha Bucktrout, Lisa H Butterfield, et al.
Cancer Immunology Research
|
May 5, 2017
Tumor-Derived α-Fetoprotein Directly Drives Human Natural Killer-Cell Activation and Subsequent Cell Death
Lazar Vujanovic, Elizabeth C Stahl, Angela D Pardee, et al.
Journal of Translational Medicine
|
April 8, 2021
The "Great Debate" at Immunotherapy Bridge 2020, December 3rd, 2020
Paolo A Ascierto, Joshua Brody, Lisa H Butterfield, et al.
Cancer Gene Therapy
|
March 19, 2005
Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells
Jennifer A Wargo, Lana Y Schumacher, Begonya Comin-Anduix, et al.
JAMA
|
November 5, 2014
Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial
F Stephen Hodi, Sandra Lee, David F McDermott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2013
A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)
Craig L Slingluff, Sandra Lee, Fengmin Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2014
Phase I dendritic cell p53 peptide vaccine for head and neck cancer
Patrick J Schuler, Malgorzata Harasymczuk, Carmen Visus, et al.
Page
of 18